DDX58 deficiency leads to triple negative breast cancer chemotherapy resistance by inhibiting Type I IFN-mediated signalling apoptosis

Overview of attention for article published in Frontiers in oncology, March 2024

Altmetric Badge

Mentioned by

twitter: 2 X users

Readers on

mendeley: 1 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 18,656 followers.

RT @FrontOncology: New research: DDX58 deficiency leads to triple negative breast cancer chemotherapy resistance by inhibiting Type I IFN-m…

15 Mar 2024

Reply Repost Favourite

New research: DDX58 deficiency leads to triple negative breast cancer chemotherapy resistance by inhibiting Type I IFN-mediated signalling apoptosis: Introduction Triple-negative breast cancer (TNBC) is characterized by its aggressive nature… https://t.co

14 Mar 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.